The scientist’s investigation covers issues in Internal medicine, Endocrinology, Insulin resistance, Insulin and Diabetes mellitus. His Internal medicine study combines topics in areas such as Gastroenterology and Type 2 diabetes. His is doing research in Adiponectin, Insulin receptor, IRS2, Leptin and Adipose tissue, both of which are found in Endocrinology.
The various areas that Yasuo Terauchi examines in his Adiponectin study include Metabolic syndrome and Adipokine. His Glucose tolerance test study in the realm of Insulin resistance interacts with subjects such as Epigenetics of diabetes Type 2. His Diabetes mellitus research is multidisciplinary, incorporating perspectives in Hematocrit, Vascular permeability, Edema and Urology.
His main research concerns Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Insulin. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Type 2 Diabetes Mellitus. Insulin receptor, IRS2, Adiponectin, Glucokinase and IRS1 are subfields of Endocrinology in which his conducts study.
His Diabetes mellitus research incorporates elements of Body mass index, Obesity and Surgery. His work on Liraglutide as part of general Type 2 diabetes study is frequently linked to In patient, bridging the gap between disciplines. His Insulin resistance research is multidisciplinary, relying on both Adipose tissue, Adipocyte, Metabolic syndrome and Leptin.
His primary areas of investigation include Internal medicine, Type 2 diabetes, Diabetes mellitus, Endocrinology and Type 2 Diabetes Mellitus. His work on Internal medicine is being expanded to include thematically relevant topics such as Gastroenterology. His work on Empagliflozin is typically connected to In patient as part of general Type 2 diabetes study, connecting several disciplines of science.
The study incorporates disciplines such as Body mass index, Adverse effect and Confidence interval in addition to Diabetes mellitus. His Endocrinology study typically links adjacent topics like Fatty liver. His Type 2 Diabetes Mellitus research integrates issues from Postmarketing surveillance, Glucagon-like peptide 1 receptor, Pediatrics and Family medicine.
Diabetes mellitus, Internal medicine, Type 2 diabetes, Endocrinology and Glycemic are his primary areas of study. He has included themes like Adverse effect and Quality of life in his Diabetes mellitus study. His Internal medicine research includes elements of Gastroenterology and Dapagliflozin.
His work on Canagliflozin as part of general Type 2 diabetes study is frequently linked to In patient, therefore connecting diverse disciplines of science. His research on Endocrinology frequently links to adjacent areas such as Downregulation and upregulation. His work deals with themes such as Dietary carbohydrate, Carbohydrate, Dietary history and Physiology, which intersect with Glycemic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
T. Yamauchi;J. Kamon;H. Waki;Y. Terauchi.
Nature Medicine (2001)
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Toshimasa Yamauchi;Junji Kamon;Yusuke Ito;Atsushi Tsuchida.
Disruption of adiponectin causes insulin resistance and neointimal formation.
Naoto Kubota;Yasuo Terauchi;Toshimasa Yamauchi;Tetsuya Kubota.
Journal of Biological Chemistry (2002)
PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Naoto Kubota;Yasuo Terauchi;Hiroshi Miki;Hiroyuki Tamemoto;Hiroyuki Tamemoto.
Molecular Cell (1999)
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.
Hiroyuki Tamemoto;Takashi Kadowaki;Kazuyuki Tobe;Takeshi Yagi.
Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis
Toshimasa Yamauchi;Junji Kamon;Hironori Waki;Yasushi Imai.
Journal of Biological Chemistry (2003)
PPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
Toru Akune;Shinsuke Ohba;Satoru Kamekura;Masayuki Yamaguchi.
Journal of Clinical Investigation (2004)
Adiponectin Stimulates AMP-Activated Protein Kinase in the Hypothalamus and Increases Food Intake
Naoto Kubota;Wataru Yano;Tetsuya Kubota;Tetsuya Kubota;Toshimasa Yamauchi.
Cell Metabolism (2007)
The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance
Toshimasa Yamauchi;Junji Kamon;Hironori Waki;Koji Murakami.
Journal of Biological Chemistry (2001)
Insulin/Foxo1 Pathway Regulates Expression Levels of Adiponectin Receptors and Adiponectin Sensitivity
Atsushi Tsuchida;Toshimasa Yamauchi;Yusuke Ito;Yusuke Hada.
Journal of Biological Chemistry (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: